GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Buildings And Improvements : ₦118 Mil (As of Jun. 2023)

View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Buildings And Improvements?

GlaxoSmithKline Consumer Nigeria's quarterly buildings and improvements stayed the same from Sep. 2022 (₦118 Mil) to Dec. 2022 (₦118 Mil) but then increased from Dec. 2022 (₦118 Mil) to Jun. 2023 (₦118 Mil).

GlaxoSmithKline Consumer Nigeria's annual buildings and improvements declined from Dec. 2020 (₦807 Mil) to Dec. 2021 (₦162 Mil) and declined from Dec. 2021 (₦162 Mil) to Dec. 2022 (₦118 Mil).

GlaxoSmithKline Consumer Nigeria Buildings And Improvements Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Buildings And Improvements Chart

GlaxoSmithKline Consumer Nigeria Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Buildings And Improvements

Get a 7-Day Free Trial

721.40

629.70

806.85

161.78

118.34

GlaxoSmithKline Consumer Nigeria Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23
Buildings And Improvements	Get a 7-Day Free Trial															118.34	118.34	118.34	118.34	118.34

GlaxoSmithKline Consumer Nigeria Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA

Website

https://www.ng.gsk.com

GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines